Nigar Yilmaz

Nigar Yilmaz

Auto-generated profile, based on publicly available information

Nigar Yilmaz

Department of Biochemistry, Faculty of Medicine, Mugla Sitki Kocman University, Mugla, Turkey

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2015 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
SKSerdar Kalemci
Serdar Kalemci
YTYaşar Topal
Yaşar Topal
SÇSerkan Yaşar Çelik
Serkan Yaşar Çelik
NYNigar Yilmaz
Nigar Yilmaz
HBHalil Beydilli
Halil Beydilli
IAIrfan Altuntas
Irfan Altuntas
The aim of the present study was to assess the protective effect of silibinin against methotrexate (MTX)-induced pulmonary toxicity. Rats were divided into four groups (MTX, MTX + silibinin, silibinin and control. MTX was injected intraperitoneally (i.p) into female Wistar rats (10 mg/kg/day for 3 days), which resulted in significant increases in the serum levels of alanine aminotransferase, aspartate aminotransferase and oxidant enzymes, including nitric oxide and myeloperoxidase. Furthermore, significant reductions were detected in the serum activity levels of the antioxidative enzymes, glutathione peroxidase and superoxide dismutase, when compared with the control group. However, administration of silibinin (100 mg/kg/day for 10 days, i.p.) was shown to ameliorate the MTX-induced pulmonary toxicity, as indicated by the normalization of the oxidative stress parameters. Furthermore, silibinin treatment was demonstrated to reduce the histopathological changes associated with MTX. In conclusion, silibinin exhibited protective effects against MTX-induced pulmonary toxicity, which may be attributed to its antioxidant activity.

1 December 2010 in Current Therapeutic Research
Verified
Journal Article
Closed access
OOOrhan Veli Ozkan
Orhan Veli Ozkan
OOOktay Hasan Ozturk
Oktay Hasan Ozturk
MAMehmet Aydin
Mehmet Aydin
NYNigar Yilmaz
Nigar Yilmaz
IYIbrahim Yetim
Ibrahim Yetim
SSSadik Sogut
Sadik Sogut

3 May 2020 in Hemoglobin
Verified
Journal Article
Closed access
PCPetek Uzay Cetinkaya
Petek Uzay Cetinkaya
FAFatih Azik
Fatih Azik
VKVolkan Karakus
Volkan Karakus
BHBulent Huddam
Bulent Huddam
NYNigar Yilmaz
Nigar Yilmaz
Chronic anemia, transfusion-associated iron deposition, and chelating agents lead to renal impairment in β-thalassemia (β-thal) patients. The present study aimed to determine the most reliable and practical method in assessing and predicting renal injury in β-thal major (β-TM) patients. Therefore, we assessed the predictive values of urine β2-microglobulin (β2-MG) and neutrophil gelatinase-associated lipocalin (NGAL) levels, their ratios to urine creatinine, and serum endocan level. Sixty β-TM patients and 30 healthy controls were included. Renal functions of the patients and controls were evaluated by means of urine protein/creatinine ratio, urine β2-MG, urine NGAL, and serum endocan level. The β-TM and control groups were comparable in terms of the demographic characteristics. Of the β-TM patients, 26.7% had glomerular hyperfiltration and 41.7% had proteinuria. Compared with the control group, the β-TM group had significantly higher levels of urine protein/creatinine, urine β2-MG, urine β2-MG/creatinine, urine NGAL, urine NGAL/creatinine, and serum endocan. These parameters did not differ between the chelating agent subgroups in the patient group. Urine β2-MG/creatinine and NGAL/creatinine ratios were the parameters with high specificity in predicting proteinuria. There were significant correlations of urine β2-MG, urine NGAL, and serum endocan levels with serum ferritin concentration. Urine β2-MG/creatinine, NGAL/creatinine, and protein/creatinine ratios were correlated with each other in the patient group. Positive correlations of urine β2-MG, urine NGAL, and serum endocan levels with serum ferritin concentration indicated that iron deposition was associated with endothelial damage and renal injury.